The HARMONY Alliance is participating in the 24th Annual Congress of the European Hematology Association (EHA).This premier hematology congress in Europe is organized from 13-16 June, 2019 in RAI Amsterdam, The Netherlands. The program includes every subspecialty in hematology, as well as networking opportunities with experts from all around the world. EHA is a HARMONY Partner.
The HARMONY Alliance uses big data analytics to accelerate the development of personalized treatments for patients with Hematologic Malignancies. HARMONY is a unique partnership of more than 80 public, private and patient organizations, funded by the Innovative Medicines Initiative.
HARMONY researchers are already mining the unique HARMONY Big Data Platform to address pressing research questions in ALL, AML, CLL, MDS, NHL, MM, and pediatric HMs.
Please join us in this large European endeavor to improve the care for blood cancer patients. Did we trigger your interest? Let’s connect! We are looking forward to meeting many congress attendees and to discuss the impact big data will have on health and in particular on hematology.
Learn about the HARMONY Big Data Platform and about the current 7 HARMONY Research Projects:
Speakers (updated): Prof Bob Löwenberg, Erasmus MC, The Netherlands; Pam Bacon, Celgene, Switzerland; Guillermo Sanz, HULAFE, Spain; Zack Pemberton-Whiteley, Acute Leukemia Advocates Network; Anthony Moorman, Newcastle University, United Kingdom; Lars Bullinger, Charité University Medicine, Germany; Lesley-Ann Sutton, ERIC; Pierre Fenaux, AP-HP, France; Allessandra Larocca, Università di Torino, Italy; Natacha Bolaños, Lymphoma Coallition; Bruno Costa, Celgene, Switzerland; Jesus Maria Hernandez Rivas, IBSAL.
Become involved and find out how big data can benefit your research.
We are looking forward to sharing our ideas and goals about big data in hematology.
Professionals with an interest in Big Data & Hematology are invited to join our session and meeting. Please note, in order to attend, you need to be registered as an EHA conference participant. For more information contact the HARMONY Communication Office.
The HARMONY Alliance is a project funded by the Innovative Medicines Initiative. HARMONY is a unique multi-stakeholder Public-Private-Partnership and consists of Partners, the Patient Cluster and Associated Members, totalling to 80 organizations from 22 European countries. HARMONY focusses on 7 Hematologic Malignancies. Read about the HARMONY Big Data Platform and the HARMONY Anonymization Concept.
The EHA Congress is a forum for original data, hematological innovation and evidence-based knowledge of primary clinical relevance. The congress also provides Satellite Symposia, Updates-in-Hematology and an exhibition organized by pharmaceutical companies, national and international non-profits. The program provides a comprehensive overview of hematology while still being easy to navigate.
Interested to learn more about the HARMONY activities during the 23rd Congress of EHA, organized in June, 2018 in Stockholm, Sweden?
Never participated in the Annual Congress of EHA? It is a flagship meeting held in a major European city every June—a significant meeting place for hematologists from every area of specialization with over 17,000 participants. View the impression of the previous congress in Stockholm, Sweden
Receive the latest news. Click here to subscribe!